After the post hoc comparisons using LSD were performed, our results demonstrated that both MetS and non-MetS patients had notably higher IL-6 levels compared to normal controls (both P < 0.001), and increased levels of IL-6 were also more pronounced in MetS patients compared to non-MetS patients (P = 0.032). Here, IL6 is linked to metabolic syndrome.